Results 191 to 200 of about 3,661 (256)

CO2‐Derived Architected Carbons for Sustainable Energy Conversion and Storage

open access: yesEcoMat, Volume 8, Issue 8, August 2026.
CO2‐derived carbon architectures are systematically engineered via thermochemical, electrochemical, and hybrid pathways to tailor electronic structure, interfacial charge transfer, and catalytic functionality. These materials demonstrate versatile performance across electrocatalysis and energy storage, establishing a coherent framework that links ...
Mohd Ubaidullah   +7 more
wiley   +1 more source

Structure–Performance Relationships of Commercial Cathode Gas Diffusion Layers in High‐Temperature PEM Fuel Cells

open access: yesFuel Cells, Volume 26, Issue 4, August 2026.
ABSTRACT The influence of cathode gas diffusion layer (GDL) architecture on the performance of high‐temperature proton exchange membrane fuel cells (HT‐PEMFCs) remains insufficiently understood, particularly for commercially available materials with different substrate and microporous layer (MPL) designs. In this study, six commercial cathode GDLs were
Ahyeon Won   +5 more
wiley   +1 more source

The Role of Native Binder in Controlling the Polytetrafluoroethylene Distribution in Gas Diffusion Layers for Proton Exchange Membrane Fuel Cells

open access: yesFuel Cells, Volume 26, Issue 4, August 2026.
ABSTRACT Gas diffusion layers (GDLs), a critical component in H2${\rm H}_{2}$/O2${\rm O}_{2}$ proton exchange membrane fuel cells (PEMFCs), are commonly treated with polytetrafluoroethylene (PTFE) for controlling hydrophobicity. However, the influence of the GDL's native microstructure on the final PTFE spatial distribution is still poorly understood ...
Dylan Schulz   +3 more
wiley   +1 more source

Investigation into EHR data coverage in the All of Us Research Program via linkage to health insurance claims. [PDF]

open access: yesPLoS One
Yang Y   +7 more
europepmc   +1 more source

The Real‐World Safety Profile of Immune Checkpoint Inhibitors in Melanoma: FAERS Pharmacovigilance Analysis Complemented by Randomized Trial Evidence

open access: yesHealth Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background and Aims Melanoma can be effectively treated with immune checkpoint inhibitors (ICIs), but information regarding the risks of treatment‐related adverse events (trAEs), immune‐related adverse events (irAEs), and real‐world adverse events (AEs) is scarce.
Yiwei Chen   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy